|
[1]
|
Chinese Center for Disease Control and Prevention (2022) COVID-19 Clinical and Surveillance Data—December 9, 2022 to February 23, 2023, China.
https://weekly.chinacdc.cn/index.htm
|
|
[2]
|
Sigal, A., Milo, R. and Jassat, W. (2022) Estimating Disease Severity of Omicron and Delta SARS-CoV-2 Infections. Nature Reviews Immunology, 22, 267-269. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Wang, Q., Iketani, S., Li, Z., et al. (2023) Alarming Antibody Evasion Properties of Rising SARS-CoV-2 BQ and XBB Subvariants. Cell, 186, 279-286.e8. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
国家卫生健康委, 国务院联防联控机制. 2022年11月29日新闻发布会[R/OL].
http://www.nhc.gov.cn/xwzb/webcontroller.do?titleSeq=11490&gecstype=1, 2022-11-29.
|
|
[5]
|
国家卫生健康委. 关于对新型冠状病毒感染实施“乙类乙管”的总体方案[A/OL].
http://www.nhc.gov.cn/xcs/zhengcwj/202212/e97e4c449d7a475794624b8ea12123c6.shtml, 2022-12-26.
|
|
[6]
|
河南省人民政府, 省政府新闻办. 河南省统筹做好新冠病毒感染疫情防控工作新闻发布会[R/OL].
https://www.henan.gov.cn/2023/01-09/2669528.html, 2023-01-09.
|
|
[7]
|
国家卫生健康委, 国务院联防联控机制. 2022年11月29日新闻发布会[R/OL].
http://www.nhc.gov.cn/xwzb/webcontroller.do?titleSeq=11497&gecstype=1, 2022-11-14.
|
|
[8]
|
Our World in Data (2023) Coronavirus Pandemic (COVID-19).
https://ourworldindata.org/coronavirus
|
|
[9]
|
Ge, Y., Martinez, L., Sun, S., et al. (2021) COVID-19 Transmission Dynamics among Close Contacts of Index Patients with COVID-19: A Popu-lation-Based Cohort Study in Zhejiang Province, China. JAMA Internal Medicine, 181, 1343- 1350. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Shrestha, N.K., Canosa, F.M., Nowacki, A.S., et al. (2020) Distribution of Transmission Potential during Non-Severe COVID-19 Illness. Clinical Infectious Diseases, 71, 2927-2932. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
北京卫健委. 阳性感染者应具备什么条件才能解除居家隔离[EB/OL].
http://wjw.beijing.gov.cn/wjwh/ztzl/xxgzbd/gzbdjkts/202212/t20221219_2880663.html, 2023-02-19.
|
|
[12]
|
Yilma, M., Taye, G., Kifle, A., et al. (2021) Hospitalization, Recovery, Death, Incubation Period and Severity of COVID-19: A Systematic Review. Ethiopian Journal of Health Development, 35, 76-81.
|
|
[13]
|
刘梦颖, 梁雪梅, 林虎, 等. 95例医务人员接种新冠灭活疫苗后特异性抗体分析[J]. 中华医院感染学杂志, 2022, 32(22): 3497-3501.
|
|
[14]
|
Zhang, Y.J., Zeng, G., et al. (2021) Safety, Tolerability, and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in Healthy Adults Aged 18-59 Years: A Randomised, Double-Blind, Placebo-Controlled, Phase 1/2 Clinical Trial. The Lancet Infec-tious Diseases, 21, 181-192. [Google Scholar] [CrossRef]
|
|
[15]
|
李明爽, 闫婷婷, 郑徽, 等. 新型冠状病毒疫苗接种与感染Delta或Omicron变异株患者临床严重程度的关联分析[J]. 中国疫苗和免疫, 2022, 28(3): 377-380.
|
|
[16]
|
Chevaisrakul, P., Lumjiaktase, P., Kietdumrongwong, P., et al. (2023) Hybrid and Herd Immunity 6 Months after SARS-CoV-2 Exposure among Individuals from a Community Treatment Program. Scientific Reports, 13, Article No. 763. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Li, H., Cheng, L., Tao, J., et al. (2022) Knowledge and Willing-ness to Receive a COVID-19 Vaccine: A Survey from Anhui Province, China. Human Vaccines & Immunotherapeutics, 18, Article ID: 2024064. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
李雨婷, 范永君, 韩常新. 辽宁省大连市新型冠状病毒肺炎疫情后其他传染病流行特征变化分析[J]. 预防医学论坛, 2023, 29(1): 54-57.
|
|
[19]
|
朱也凡, 张书志, 段春梅, 等. 新型冠状病毒肺炎疫情防控措施对上海市嘉定区法定传染病发病率的影响[J]. 疾病监测, 2023, 38(2): 181-184.
|
|
[20]
|
国家卫健委. 关于印发以医联体为载体做好新冠肺炎分级诊疗工作方案的通知[EB/OL].
http://www.gov.cn/xinwen/2022-12/08/content_5730651.htm, 2022-12-08.
|
|
[21]
|
王淑云, 孙泽生. 分级诊疗改革对患者满意度和诊疗选择行为的影响[J]. 管理工程学报, 2021, 35(6): 115-127.
|